Earth Science Tech (ETST) Common Equity (2012 - 2026)
Earth Science Tech's (ETST) quarterly Common Equity came in at $7.4 million in Q2 2026, up 71.77% on a YoY basis from $4.3 million in Q2 2025, and up 4.59% quarter-over-quarter from $7.0 million in Q1 2026.
Analysis
Earth Science Tech (ETST) Common Equity (2012 - 2026) Analysis & Trends
Earth Science Tech (ETST) has reported Common Equity for 13 consecutive years, with $7.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity rose 71.77% year-over-year to $7.4 million; the trailing twelve-month figure through Jun 2026 stood at $7.4 million (up 71.77% YoY), and the FY2026 full-year result was $7.0 million, up 82.82% from the prior year.
- Common Equity improved to $7.4 million in Q2 2026 per ETST's latest filing, from $7.0 million in the prior quarter.
- Across five years, Common Equity topped out at $7.4 million in Q2 2026 and bottomed at -$2.0 million in Q3 2022.
- Historically, Common Equity has averaged $2.5 million across 5 years, with a median of $2.7 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Common Equity decreased 20.71% in 2022, then soared 352.5% in 2023.
- Over 5 years, Common Equity stood at -$870350.0 in 2022, then jumped by 352.5% to $2.2 million in 2023, then surged by 49.27% to $3.3 million in 2024, then surged by 76.9% to $5.8 million in 2025, then rose by 26.9% to $7.4 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $7.4 million, $7.0 million, and $5.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 7.76 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 14.26 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 4.08 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 33.02 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | -1.77 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -191.48 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 597.21 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 768.16 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 42.44 Mn |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn | 7.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.36 Mn |
| Mar 31, 2026 | 7.04 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.08 Mn |
| Jun 30, 2025 | 4.29 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 3.17 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | -870,350.00 |
| Sep 30, 2022 | -2.03 Mn |
| Jun 30, 2022 | -1.96 Mn |
| Mar 31, 2022 | -1.81 Mn |
| Dec 31, 2021 | -1.78 Mn |
| Sep 30, 2021 | -1.68 Mn |